-
Mashup Score: 1
Modeling study shows cost-effectiveness to cut colorectal cancer incidence, mortality
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 11Updates in eosinophilic gastrointestinal diseases - 2 year(s) ago
Patients with non-EoE eosinophilic GI diseases can go unrecognized for years for a variety of reasons.
Source: www.mdedge.comCategories: General Medicine News, Latest HeadlinesTweet-
From #DDW2022: Dr. Peterson discusses updates in eosinophilic gastrointestinal diseases: https://t.co/UNrIKsSRXX https://t.co/hnUWhnuE3Z
-
-
Mashup Score: 0Understanding GERD phenotypes - 2 year(s) ago
Because the mechanisms driving symptoms vary across patients, phenotyping patients via a step-wise diagnostic framework personalizes management in GERD.
Source: www.mdedge.comCategories: General Medicine News, Latest HeadlinesTweet-
Approximately 30% of U.S. adults experience troublesome reflux symptoms of heartburn, regurgitation and noncardiac chest pain. Phenotyping patients via a step-wise diagnostic framework effectively guides personalized management in #GERD. #DDW2022 https://t.co/UWrZ1buNQy https://t.co/MpzdaREp6V
-
-
Mashup Score: 08 Must-Read GI Studies for the Primary Care Physician - 2 year(s) ago
Gastroenterologist Vivek Kaul, MD, reviews his top picks for primary care clinicians from the 2022 Digestive Disease Week, the premier meeting for the GI specialty.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
Gastroenterologist Vivek Kaul, MD, reviews his top picks for primary care clinicians from #DDW2022 including papers on the esophagus and the colon and then finishing up with the liver. https://t.co/kYBU2XGuaZ https://t.co/jb6CClffxO
-
-
Mashup Score: 2
In a Healio video exclusive, Remo Panaccione, MD, discusses results from long-term, pooled analyses of adult patients treated with ustekinumab for inflammatory bowel disease. “We know that Stelara (ustekinumab, Janssen) is a highly effective therapy in inflammatory bowel disease when it’s either used first-line or in patients who have been exposed to other advanced therapies,”
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
In a Healio video exclusive, @RPanaccione discusses results from long-term, pooled analyses of adult patients treated with #ustekinumab for #IBD #DDW2022 #GITwitter #MedTwitter https://t.co/cReeKxSJXB https://t.co/WEPXb08c9S
-
-
Mashup Score: 0Artificial Intelligence Colonoscopy System Shows Promise - 2 year(s) ago
A new artificial intelligence colonoscopy system improved the accuracy of experienced endoscopists in the United States.
Source: MedscapeCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
A new AI system can help expert endoscopists improve their colonoscopies, a new study indicates. #DDW2022 https://t.co/zsU5AKbfF2
-
-
Mashup Score: 0Dr Christopher Thompson Discusses GI Innovation Presented at DDW - 2 year(s) ago
Christopher Thompson, MD, MSc, FASGE, FACG, AGAF, FJGES, director of endoscopy and codirector of the Center for Weight Management and Wellness at Brigham & Women’s Hospital, professor of medicine at Harvard Medical School, discusses a session on gastrointestinal [GI] invention at the recent conference, Digestive Disease Week, held May 21-24 in San Diego, California.
Source: AJMCCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Dr Christopher Thompson (@MetabolicEndo) Discusses #GI Innovation Presented at #DDW2022 https://t.co/bLvL750z5c https://t.co/558GUXxzFl
-
-
Mashup Score: 2
Three experts discuss emerging microbiome-directed treatments for recurrent Clostridioides difficile infection (CDI) from a live symposium at DDW 2022.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
#ICYMI from #DDW2022: Learn from experts on the microbiome, gut dysbiosis, and current and emerging treatments for recurrent Clostridioides difficile infection. #CDI #Symposium #CME #MedEd https://t.co/zhxsyHgr4H https://t.co/ahU2bhzNAN
-
-
Mashup Score: 1
Here are Healio’s top 10 peer-tested articles from Digestive Disease Week 2022, which highlight research on restrictive diets, gallstone disease, dog ownership and Crohn’s disease, COVID-19 antibody response and more.Two restrictive diets were superior in reducing symptoms compared with optimized medical treatment alone in patients with irritable bowel syndrome.
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
Here are @GoHealio’s #top10 peer-tested articles from #DDW2022, which highlight research on restrictive #diets, #gallstone #disease, dog ownership and #Crohnsdisease, #COVID19 antibody response and more @DDWMeeting #GITwitter #MedTwitter https://t.co/D9qnuUp4KY
-
-
Mashup Score: 1
SAN DIEGO — In a Healio video exclusive, Marla C. Dubinsky, MD, discusses results from the ELEVATE UC trials, in which once daily etrasimod induced clinical remission in patients with ulcerative colitis. “It was really exciting to see that we have yet another potential therapy that will be approved in this new class of small molecules known as S1P receptor modulators,” Dubsinky,
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
RT @EdwardLoftus2: VIDEO: Oral S1P receptor modulator induces clinical remission in UC https://t.co/OELT490oLq @HealioGastro #DDW2022 #Marl…
-
ICYMI: "We are able to find a cost reduction as a whole, which is surprising because the primary use of #artificial intelligence increases the costs, but it can be done by the prevention effect of #colorectal cancer." @AmerGastroAssn #DDW2022 #AGAConfRep https://t.co/hlcY0Ufdvm